Latest News & Features
Americas
Biotechnology company Acorda Therapeutics has urged the Patent Trial and Appeal Board not to institute an inter partes review petition filed by the Coalition for Affordable Drugs, an organisation linked to hedge fund manager Kyle Bass. 16 December 2015
Americas
Parties are required to provide 180 days’ notice to a patent owner before marketing a biosimilar version of its drug, a US district court has ruled. 15 December 2015
Americas
Pharmaceutical company Gilead Sciences has settled its patent dispute with Indian-based rival Natco Pharma over an attempt to market a generic version of its Tamiflu product. 14 December 2015
Americas
The Patent Trial and Appeal Board has rejected the Coalition for Affordable Drugs' attempt to invalidate a patent covering Pozen’s Vimovo (naproxen and esomeprazole magnesium) drug. 11 December 2015
Big Pharma
Teva has been handed a victory after a patent covering its multiple sclerosis drug Copaxone (glatiramer acetate) was declared valid until 2030. 10 December 2015
Americas
Law firm Merchant & Gould has hired Alireza Behrooz as a partner in the firm’s chemical and life sciences group in Washington, DC. 10 December 2015
Big Pharma
The application of supplementary protection certificates to the unitary patent system poses numerous complexities, both legal and practical, as Christopher Stothers and Paul Abbott of Arnold & Porter describe. 10 December 2015
Americas
AstraZeneca has agreed to let distributor Perrigo Company sell its Entocort (budesonide) drug. 9 December 2015
Generics
Unimed Pharmaceuticals, a subsidiary of life sciences company AbbVie, has slammed generics maker Sandoz with a lawsuit alleging infringement of 11 of its patents. 8 December 2015
Americas
The US government has asked pharmaceutical company Mylan to testify with information on the price of a generic antibiotic product it makes. 7 December 2015